The Surveillance Partnership to Improve Data for Action on AMR (SPIDAAR)

Project overview

SPIDAAR is a pilot partnership designed to strengthen the generation and access to AMR data in Ghana, Kenya, Malawi, and Uganda. The partnership aims to implement a surveillance program in the four countries to measure the development and spread of drug resistance through systematic collection, analysis, and reporting of AMR data, and leverage this data to inform public health policy and clinical practice.

Topics

Antimicrobial Resistance
Health Systems, Primary Care
Infectious Diseases

Capabilities

Capacity Building and Education
Convening

Funders/Sponsors

Pfizer; Wellcome Trust

Related resources

Innovations in Healthcare. Sustainability Planning for Surveillance of Antimicrobial Resistance: Digital Case Studies Series on Antimicrobial Resistance from Kenya, Ghana, and Uganda. May 2024. (PDF)

Related news

Implementing AMR Surveillance Sustainably in Africa: Insights and Lessons from Ghana, Kenya, and Uganda

Tue Jun 18 2024 - Antimicrobial resistance (AMR) is a significant global public health menace.When antimicrobials are ineffective against previously treatable infections, it undermines the ability of health systems around the world to treat even minor infections, resulting in more… Read more